23 results
8-K
EX-10.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced … , proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any
8-K
EX-1.1
NEXI
Neximmune Inc
17 Jun 22
Entry into a Material Definitive Agreement
4:51pm
, have a Material Adverse Effect; (iv) has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation … , enforcement, investigation, arbitration or other action threatened; (v) has not received written notice that any court or arbitrator or governmental
DEF 14A
5va1uowefvel6
3 May 22
Definitive proxy
4:16pm
S-3
EX-4.5
nmurlpmfiwvzj09y1iin
9 Mar 22
Shelf registration
5:14pm
S-3
EX-4.6
ilh3i i35b
9 Mar 22
Shelf registration
5:14pm
8-K
EX-10.1
pwuen2r 8etyaae70
17 Feb 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.2
tp0f0ufuhdhjr
9 Aug 21
NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates
4:26pm
10-K
yw272 3q7ifd6x
31 Mar 21
Annual report
4:02pm
424B4
keoc6k2auhudtt9
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
gh0myb8f6 p7zy2k5
8 Feb 21
IPO registration (amended)
7:29am
S-1/A
EX-10.1
8krlhr0k
8 Feb 21
IPO registration (amended)
7:29am
S-1/A
EX-1.1
rd18wsasfig5 xfchd2
8 Feb 21
IPO registration (amended)
7:29am
S-1
m9qr3l
19 Jan 21
IPO registration
4:38pm
S-1
EX-3.3
8chvvfwju2p
19 Jan 21
IPO registration
4:38pm
DRS/A
EX-3.3
qusqwapgr9
15 Jan 21
Draft registration statement (amended)
12:00am